Jakarta, April 9 -- Indonesia's Food and Drug Monitoring Agency (BPOM) has approved the expanded use of the measles vaccine for at-risk adult groups as part of efforts to control outbreaks.

The move responds to a public health emergency triggered by rising measles cases in several regions, BPOM head Taruna Ikrar said in Jakarta on Thursday.

Based on Health Ministry data, 58 measles outbreaks were recorded in 39 districts and cities across 14 provinces as of the 11th week of 2026.

"Although this shows a 93 percent decline from a peak of 2,220 cases to 146 cases in mid-March 2026, strict surveillance remains essential as transmission risks persist, including among adults with low immunization coverage," Ikrar said.

He said the decision ...